Friday, 15 December 2017

Cannabidiol (CBD), an extract of marijuana, has beneficial effects in patients with schizophrenia, finds a new multicenter double-blind randomized controlled trial


Cannabidiol (CBD), an extract of marijuana, has beneficial effects in patients with schizophrenia, finds a new multicenter double-blind randomized controlled trial: http://ift.tt/2CclKQJ Read more... http://ift.tt/2ogWBCa

No comments:

Post a Comment